ReviewMolecules (Basel, Switzerland)2025
Design and Application of Conjugated Oligomers for Imaging and Anticancer and Antibacterial Treatment.
Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The excessive use of antibiotics and the rise in resistant strains have significantly contributed to increased mortality rates associated with tumors and infectious diseases, posing a severe threat to public health. Consequently, there is an urgent need to enhance detection and treatment strategies for critical diseases, including cancer and pathogenic microorganisms. Conjugated oligomers, formed by a limited number of repeating conjugated units linked through covalent bonds, exhibit a high potential for various applications in biological monitoring and disease diagnosis due to their controllable molecular weight, precise molecular structure, and excellent photostability. Therefore, it is particularly essential to design and optimize the structure of conjugated oligomers to improve their biocompatibility and therapeutic efficacy. In this review article, we summarize recent advancements in applying conjugated oligomers in imaging, cancer therapy, and antibacterial treatment. Furthermore, this article critically examines the challenges in their biological applications, underscoring the need for continued innovation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.